Home
Conditions
Lymphoma, T-Cell

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

185 public trials 53 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Recruiting

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

NCT05313243

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Yale Smilow Cancer Hospital New Haven, Connecticut, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

NCT03017820

Conditions: B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bone Marrow Diseases, +46 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

NCT07278856

Conditions: Follicular Helper T-Cell Lymphoma, Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type, Follicular Helper T-Cell Lymphoma, Follicular-Type, +13 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT06131801

Conditions: ALL, AML, Acute Lymphocytic Leukemia, +50 more
Locations: Children's Hospital Colorado Aurora, Colorado, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

A Registry for People With T-cell Lymphoma

NCT05978141

Conditions: Adult T-Cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, +54 more
Locations: City of Hope Cancer Center (Data collection only) Duarte, California, United States

UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) San Diego, California, United States

University of California San Francisco (Data collection only) San Francisco, California, United States

Stanford University Medical Center (Data collection only) Stanford, California, United States

View all 26 locations

View Trial Details

Recruiting

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

NCT07225985

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL

NCT06874946

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia

NCT06696846

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)

NCT05984147

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Omega Cancer Hospitals Visakhapatnam, Andhra Pradesh, India

Post Graduate Institute of Medical Education & Research, Chandigarh, India

Cellcure Care Cancer Pvt Ltd Ahmedabad, Gujarat, India

HCC Happiness Care and Cure Multispeciality Hospital Ahmedabad, Gujarat, India

View all 27 locations

View Trial Details

Recruiting

Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)

NCT07496229

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China

Fujian Cancer Hospital Fuzhou, Fujian, China

Guangxi Medical University Cancer Hospital Nanning, Guangxi, China

Henan Provincial People's Hospital Zhengzhou, Henan, China

View Trial Details

Lymphoma, T-Cell

Lymphoma, T-Cell trial results

Related conditions